Sponsor content
190 result(s) found, displaying 121 to 130
-
Section 14, TGO91 consentProduct(s) approved for Supply with noncompliant labelling.
-
Australian public assessment report (AusPar)Australian Public Assessment Report for Insulin degludec (rys) and Insulin aspart (rys)
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for RYZODEG 70/30 FLEXTOUCH 70% insulin degludec (rys) / 30% insulin aspart (rys) 100 U/mL solution for injection cartridge.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for RYZODEG 70/30 PENFILL 70% insulin degludec (rys) / 30% insulin aspart (rys) 100 U/mL solution for injection cartridge.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for TRESIBA PENFILL insulin degludec (rys) 100 U/mL solution for injection multidose cartridge.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for TRESIBA FLEXTOUCH insulin degludec (rys) 100 U/mL solution for injection multidose cartridge.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for TRESIBA FLEXTOUCH insulin degludec (rys) 200 U/mL solution for injection multidose cartridge.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for FIASP insulin aspart (rys) 100 units/mL solution for injection 10 mL vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for FIASP FLEXTOUCH insulin aspart (rys) 100 units/mL solution for injection 3 mL pre-filled pen.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for FIASP PENFILL insulin aspart (rys) 100 units/mL solution for injection 3 mL cartridge.